Brandywine Global Investment Management, LLC Coherus Bio Sciences, Inc. Transaction History

Brandywine Global Investment Management, LLC

$14.2 Billion
Q3 2024

A detailed history of Brandywine Global Investment Management, LLC transactions in Coherus Bio Sciences, Inc. stock. As of the latest transaction made, Brandywine Global Investment Management, LLC holds 490,545 shares of CHRS stock, worth $721,101. This represents 0.0% of its overall portfolio holdings.

Number of Shares

490,545

Previous 699,645 29.89%

Holding current value

$721,101

Previous $1.21 Million 57.85%

% of portfolio

0.0%

Previous 0.01%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$0.99 - $1.8 $207,009 - $376,380	-209,100 Reduced 29.89%	490,545 $510,000
Q2 2024 Aug 14, 2024	BUY	$1.58 - $2.51 $227,046 - $360,686	143,700 Added 25.85%	699,645 $1.21 Million
Q4 2023 Feb 09, 2024	SELL	$1.59 - $3.85 $175,377 - $424,655	-110,300 Reduced 16.56%	555,945 $1.85 Million
Q3 2023 Nov 13, 2023	BUY	$3.74 - $5.45 $979,132 - $1.43 Million	261,800 Added 64.73%	666,245 $2.49 Million
Q2 2023 Aug 11, 2023	BUY	$3.79 - $8.3 $1.34 Million - $2.94 Million	354,100 Added 703.35%	404,445 $1.73 Million
Q3 2022 Nov 14, 2022	SELL	$7.17 - $13.87 $13,300 - $25,728	-1,855 Reduced 3.55%	50,345 $484,000
Q2 2022 Aug 11, 2022	SELL	$5.86 - $13.23 $45,708 - $103,194	-7,800 Reduced 13.0%	52,200 $378,000
Q4 2021 Feb 11, 2022	SELL	$15.81 - $18.99 $238,825 - $286,862	-15,106 Reduced 20.11%	60,000 $958,000
Q3 2021 Nov 12, 2021	SELL	$12.68 - $17.79 $9,040 - $12,684	-713 Reduced 0.94%	75,106 $1.21 Million
Q2 2021 Aug 13, 2021	BUY	$12.95 - $15.41 $981,856 - $1.17 Million	75,819 New	75,819 $1.05 Million
Q1 2021 May 13, 2021	SELL	$14.42 - $21.39 $5.2 Million - $7.71 Million	-360,344 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$16.56 - $18.94 $846,547 - $968,212	51,120 Added 16.53%	360,344 $6.26 Million
Q3 2020 Nov 12, 2020	BUY	$17.41 - $19.89 $2.72 Million - $3.11 Million	156,289 Added 102.19%	309,224 $5.67 Million
Q2 2020 Aug 14, 2020	BUY	$14.43 - $19.16 $2.21 Million - $2.93 Million	152,935 New	152,935 $2.73 Million

Others Institutions Holding CHRS

# of Institutions

134

Shares Held

77.9M

Call Options Held

40.7K

Put Options Held

50.1K

View Full List

About Coherus BioSciences, Inc.

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $114M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

More about CHRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brandywine Global Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brandywine Global Investment Management, LLC with notifications on news.

Account

Brandywine Global Investment Management, LLC Coherus Bio Sciences, Inc. Transaction History